Additionally, Boermann and colleagues tested the effects of blocking NKG2D, DNAM-1, NKp30, NKp44, and NKp46 on primary human NK cells prior to co-culture with rhabdomyosarcoma cell lines (66). The gene discussed is CD226; the disease is rhabdomyosarcoma.